The encapsulation of lycopene in nanoliposomes enhances its protective potential in methotrexate-induced kidney injury model

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Stojiljkovic, Nenad ^a   Ilic, Sonja ^a   Jakovljevic, Vladimir ^b,c   Stojanovic, Nikola ^a   Stojnev, Slavica ^a   Kocic, Hristina ^d   Stojanovic, Marko ^a   Kocic, Gordana ^a  

^a UNIVERSITY OF NI   (Serbia)

^b University of Kragujevac Medical Faculty   (Serbia)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF MARIBOR   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CREATININE; LIPOSOME; LYCOPENE; MALONALDEHYDE; METHOTREXATE; MYELOPEROXIDASE; NANOCARRIER; NANOLIPOSOME; UNCLASSIFIED DRUG; UREA; CAROTENOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG STABILITY; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VITRO STUDY; KIDNEY INJURY; KIDNEY TISSUE; LIPID PEROXIDATION; MALE; NANOENCAPSULATION; NEPHROTOXICITY; NONHUMAN; PH; PROTEIN DETERMINATION; RAT; RENAL PROTECTION; SUSTAINED DRUG RELEASE; UREA BLOOD LEVEL; ANIMAL; CHEMICALLY INDUCED; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CAROTENOIDS; KIDNEY; KIDNEY DISEASES; MALE; METHOTREXATE; RATS; RATS, WISTAR;

EID: 85053352375     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/2627917     Document Type: Article

References (44)

1. B. C. Widemann, F. M. Balis, B. Kempf-Bielack et al., “High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma,” Cancer, vol. 100, no. 10, pp. 2222-2232, 2004.
2. S. Kivity, Y. Zafrir, R. Loebstein, R. Pauzner, M. Mouallem, and H. Mayan, “Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients,” Autoimmunity Reviews, vol. 13, no. 11, pp. 1109-1113, 2014.
3. N. Jahovic, G. Sener, H. Cevik, Y. Ersoy, S. Arbak, and B. C. Yegen, “Amelioration of methotrexate-induced enteritis by melatonin in rats,” Cell Biochemistry & Function, vol. 22, no. 3, pp. 169-178, 2004.
4. I. Asvadi, B. Hajipour, A. Asvadi, N. A. Asl, L. Roshangar, and A. Khodadadi, “Protective effect of pentoxyfilline in renal toxicity after methotrexate administration,” European Review for Medical and Pharmacological Sciences, vol. 15, no. 9, pp. 1003-1009, 2011.
5. N. Vardi, H. Parlakpinar, B. Ates, A. Cetin, and A. Otlu, “The protective effects of Prunus armeniaca L (apricot) against methotrexate-induced oxidative damage and apoptosis in rat kidney,” Journal of Physiology and Biochemistry, vol. 69, no. 3, pp. 371-381, 2013.
6. S. S. Palabiyik, P. Erkekoglu, N. D. Zeybek et al., “Protective effect of lycopene against ochratoxin A induced renal oxidative stress and apoptosis in rats,” Experimental and Toxicologic Pathology, vol. 65, no. 6, pp. 853-861, 2013.
7. W. Stahl and H. Sies, “Antioxidant activity of carotenoids,” Molecular Aspects of Medicine, vol. 24, no. 6, pp. 345-351, 2003.
8. A. Atessahin, S. Yilmaz, I. Karahan, A. O. Ceribasi, and A. Karaoglu, “Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats,” Toxicology, vol. 212, no. 2-3, pp. 116-123, 2005.
9. A. Dogukan, M. Tuzcu, C. A. Agca et al., “A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression,” Nutrition and Cancer, vol. 63, no. 3, pp. 427-434, 2011.
10. S. K. Sahoo, S. Parveen, and J. J. Panda, “The present and future of nanotechnology in human health care,” Nanomedi-cine: Nanotechnology, Biology, and Medicine, vol. 3, no. 1, pp. 20-31, 2007.
11. G. A. Hughes, “Nanostructure-mediated drug delivery,” Nano-medicine: Nanotechnology, Biology, and Medicine, vol. 1, no. 1, pp. 22-30, 2005.
12. M. R. Mozafari, “Bioactive entrapment and targeting using nanocarrier technologies: an introduction,” in Nanocarrier Technologies: Frontiers of Nanotherapy, M. R. Mozafari, Ed., pp. 1-16, Springer, Netherlands, 2005.
13. G. Kocic, K. Tomovic, H. Kocic et al., “Antioxidative, membrane protective and antiapoptotic effects of melatonin, in silico study of physico-chemical profile and efficiency of nanoliposome delivery compared to betaine,” RSC Advances, vol. 7, no. 3, pp. 1271-1281, 2017.
14. C. Tan, J. Xue, S. Abbas, B. Feng, X. Zhang, and S. Xia, “Lipo-some as a delivery system for carotenoids: comparative antioxidant activity of carotenoids as measured by ferric reducing antioxidant power, DPPH assay and lipid peroxidation,” Journal of Agricultural and Food Chemistry, vol. 62, no. 28, pp. 6726-6735, 2014.
15. X. Chen, L. Q. Zou, J. Niu, W. Liu, S. F. Peng, and C. M. Liu, “The stability, sustained release and cellular antioxidant activity of curcumin nanoliposomes,” Molecules, vol. 20, no. 8, pp. 14293-14311, 2015.
16. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, pp. 302-310, 1978.
17. S. Ilic, N. Stojiljkovic, S. Veljkovic et al., “Morphometric study of structural kidney damages caused by cisplatin in rats. Effects of quercetin,” Acta Microscopica, vol. 25, no. 4, pp. 128-137, 2016.
18. L. Goth, “A simple method for determination of serum catalase activity and revision of reference range,” Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143-151, 1991.
19. S. S. Jacob, P. Shastry, and P. R. Sudhakaran, “Influence of non-enzymatically glycated collagen on monocyte-mac-rophage differentiation,” Atherosclerosis, vol. 159, no. 2, pp. 333-341, 2001.
20. N. S. Radulovic, P. J. Randjelovic, N. M. Stojanovic, N. D. Cakic, G. A. Bogdanovic, and A. V. Zivanovic, “Aboriginal bush foods: a major phloroglucinol from Crimson Bottlebrush flowers (Callistemon citrinus, Myrtaceae) displays strong anti-nociceptive and antiinflammatory activity,” Food Research International, vol. 77, Part 2, pp. 280-289, 2015.
21. N. Stojiljkovic, M. Stoiljkovic, P. Randjelovic, S. Veljkovic, and D. Mihailovic, “Cytoprotective effect of vitamin C against gentamicin-induced acute kidney injury in rats,” Experimental and Toxicologic Pathology, vol. 64, no. 1-2, pp. 69-74, 2012.
22. P. Randjelovic, S. Veljkovic, N. Stojiljkovic et al., “Salicylic acid attenuates gentamicin-induced nephrotoxicity in rats,” The Scientific World Journal, vol. 2012, Article ID 390613, 6 pages, 2012.
23. M. van de Ven, M. Kattenberg, G. van Ginkel, and Y. K. Levine, “Study of the orientational ordering of carotenoids in lipid bilayers by resonance-Raman spectroscopy,” Biophysical Journal, vol. 45, no. 6, pp. 1203-1209, 1984.
24. T. Anguelova and J. Warthesen, “Degradation of lycopene, α-carotene, and β-carotene during lipid peroxidation,” Journal of Food Science, vol. 65, no. 1, pp. 71-75, 2000.
25. 2 fluid extraction,” International Journal of Current Microbiology and Applied Sciences, vol. 4, no. 3, pp. 307-320, 2015.
26. R. Singh, R. Shah, C. Turner, O. Regueira, and T. L. Vasylyeva, “N-acetylcysteine renoprotection in methotrexate induced nephrotoxicity and its effects on B-cell lymphoma,” Indian Journal of Medical and Paediatric Oncology, vol. 36, no. 4, pp. 243-248, 2015.
27. M. A. Perazella, “Crystal-induced acute renal failure,” The American Journal of Medicine, vol. 106, no. 4, pp. 459-465, 1999.
28. W. Ahmed, A. Zaki, and T. Nabil, “Prevention of methotrexate-induced nephrotoxicity by concomitant administration of garlic aqueous extract in rat,” Turkish Journal of Medical Sciences, vol. 45, no. 3, pp. 507-516, 2015.
29. B. C. Widemann and P. C. Adamson, “Understanding and managing methotrexate nephrotoxicity,” The Oncologist, vol. 11, no. 6, pp. 694-703, 2006.
30. C. L. Coleshowers, O. O. Oguntibeju, M. Ukpong, and E. J. Truter, “Effects of methotrexate on antioxidant enzyme status in a rodent model,” Medical Technology SA, vol. 24, no. 1, pp. 5-9, 2010.
31. S. K. Choi and J. S. Seo, “Lycopene supplementation suppresses oxidative stress induced by a high fat diet in gerbils,” Nutrition Research and Practice, vol. 7, no. 1, pp. 26-33, 2013.
32. V. K. Kolli, P. Abraham, B. Isaac, and D. Selvakumar, “Neutro-phil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage,” Chemotherapy, vol. 55, no. 2, pp. 83-90, 2009.
33. H. I. Atilgan, A. Aydin, M. Sadic et al., “The protective effect of lycopene on kidney against experimentally induced unilateral ureteral obstruction,” Acta Medica Mediterranea, vol. 32, pp. 1631-1636, 2016.
34. M. Sadic, H. I. Atilgan, A. Aydin et al., “Scintigraphic, histo-pathologic, and biochemical evaluation of lycopene effects on renal ischemia reperfusion injury in rats,” Serbian Archives of Medicine, vol. 145, no. 3-4, pp. 153-158, 2017.
35. U. Aman, P. Vaibhav, and R. Balaraman, “Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study,” Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 5, pp. 345-351, 2012.
36. E. Ozkan, C. Akyüz, E. Dulundu et al., “Protective effects of lycopene on cerulein-induced experimental acute pancreatitis in rats,” The Journal of Surgical Research, vol. 176, no. 1, pp. 232-238, 2012.
37. Y. C. Hou, A. Janczuk, and P. G. Wang, “Current trends in the development of nitric oxide donors,” Current Pharmaceutical Design, vol. 5, no. 6, pp. 417-441, 1999.
38. E. Oguz, S. Kocarslan, S. Tabur, H. Sezen, Z. Yilmaz, and N. Aksoy, “Effects of lycopene alone or combined with melatonin on methotrexate-induced nephrotoxicity in rats,” Asian Pacific Journal of Cancer Prevention, vol. 16, no. 14, pp. 6061-6066, 2015.
39. U. Rolle, H. Shima, and P. Puri, “Nitric oxide, enhanced by macrophage-colony stimulating factor, mediates renal damage in reflux nephropathy,” Kidney International, vol. 62, no. 2, pp. 507-513, 2002.
40. S. Yamagishi and T. Matsui, “Advanced glycation end products, oxidative stress and diabetic nephropathy,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 101-108, 2010.
41. Y. Liu, “Advanced oxidation protein products: a causative link between oxidative stress and podocyte depletion,” Kidney International, vol. 76, no. 11, pp. 1125-1127, 2009.
42. E. Uz, F. Oktem, H. R. Yilmaz, E. Uzar, and F. Ozguner, “The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester,” Molecular and Cellular Biochemistry, vol. 277, no. 1-2, pp. 165-170, 2005.
43. H. L. Hantz, L. F. Young, and K. R. Martin, “Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells,” Experimental Biology and Medicine, vol. 230, no. 3, pp. 171-179, 2016.
44. G. Krishnamoorthy, K. Selvakumar, P. Venkataraman, P. Elumalai, and J. Arunakaran, “Lycopene supplementation prevents reactive oxygen species mediated apoptosis in Sertoli cells of adult albino rats exposed to polychlorinated biphe-nyls,” Interdisciplinary Toxicology, vol. 6, no. 2, pp. 83-92, 2013.